Literature DB >> 14023662

A new quinidine preparation with sustained release.

G CRAMER, E VARNAUSKAS, L WERKO.   

Abstract

Entities:  

Keywords:  AURICULAR FIBRILLATION; QUINIDINE

Mesh：

Substances：

Year:  1963        PMID： 14023662     DOI： 10.1111/j.0954-6820.1963.tb17435.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN： 0001-6101


× No keyword cloud information.
  7 in total

1.  Comparison of quinidine plasma concentration curves following oral administration of some short- and long-acting formulations.

Authors:  G M Frigo; E Perucca; M Teggia-Droghi; G Gatti; A Mussini; J Salerno
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

2.  Serum quinidine levels after administration of three different quinidine preparations.

Authors:  R Henning; G Nyberg
Journal:  Eur J Clin Pharmacol       Date:  1973-12       Impact factor: 2.953

3.  Appraisal of electroconversion in treatment of cardiac dysrhythmias.

Authors:  L Resnekov; L McDonald
Journal:  Br Heart J       Date:  1968-11

4.  [Blood level studies on the most suitable dosage forms in long-term quinidine therapy].

Authors:  H Zettner; D Michel
Journal:  Klin Wochenschr       Date:  1971-05

5.  Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter. A multicentre study from Stockholm.

Authors:  T Södermark; B Jonsson; A Olsson; L Orö; H Wallin; O Edhag; A Sjögren; M Danielsson; G Rosenhamer
Journal:  Br Heart J       Date:  1975-05

6.  Absolute bioavailability of quinidine in two sustained release preparations.

Authors:  J P Amlie; L Storstein; B Olsson; D Fremstad; S Jacobsen
Journal:  Eur J Clin Pharmacol       Date:  1979-08       Impact factor: 2.953

7.  Quinidine dosage, with special reference to an oral loading dose schedule.

Authors:  P Collste; R Nordlander
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.